{"id":"tumor-pulsed-dendritic-cells","safety":{"commonSideEffects":[{"rate":"null","effect":"Fever"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2074849","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved by loading dendritic cells with tumor antigens, which are then presented to T-cells, triggering an immune response against cancer cells. This process can lead to the destruction of cancer cells and potentially induce long-term immune memory.","oneSentence":"Tumor-pulsed dendritic cells stimulate an immune response against cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:51:08.275Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of various cancers"}]},"trialDetails":[{"nctId":"NCT00338377","phase":"PHASE2","title":"Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-02-01","conditions":"Melanoma","enrollment":1230},{"nctId":"NCT07455071","phase":"NA","title":"A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2026-03-01","conditions":"HRD-negative Epithelial Ovarian Cancer","enrollment":9},{"nctId":"NCT05325632","phase":"PHASE2","title":"Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2021-10-28","conditions":"HER2-positive Breast Cancer","enrollment":53},{"nctId":"NCT02063724","phase":"PHASE1","title":"HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2014-10-01","conditions":"Breast Cancer","enrollment":15},{"nctId":"NCT05378464","phase":"PHASE1","title":"Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2022-05-31","conditions":"HER2-positive Breast Cancer","enrollment":28},{"nctId":"NCT05809752","phase":"PHASE1","title":"A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2023-08-22","conditions":"Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer","enrollment":18},{"nctId":"NCT01697527","phase":"PHASE2","title":"Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2012-11-02","conditions":"Malignant Neoplasm","enrollment":6},{"nctId":"NCT03396575","phase":"PHASE1","title":"Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-07-17","conditions":"Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma","enrollment":11},{"nctId":"NCT04201873","phase":"PHASE1","title":"Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2020-01-08","conditions":"Recurrent Glioblastoma","enrollment":40},{"nctId":"NCT04963413","phase":"PHASE1","title":"RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.","status":"TERMINATED","sponsor":"University of Florida","startDate":"2022-01-13","conditions":"Glioblastoma","enrollment":6},{"nctId":"NCT02775292","phase":"PHASE1","title":"Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2017-01-03","conditions":"Adult Solid Neoplasm, Childhood Solid Neoplasm, Metastatic Neoplasm","enrollment":1},{"nctId":"NCT06195618","phase":"PHASE1","title":"Personalized Vaccine for TNBC Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Universidad Nacional de Colombia","startDate":"2025-08-01","conditions":"Breast Cancer Female","enrollment":8},{"nctId":"NCT05714306","phase":"PHASE1, PHASE2","title":"PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma","status":"WITHDRAWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2023-08-01","conditions":"Ovarian Carcinoma","enrollment":""},{"nctId":"NCT05457959","phase":"PHASE1","title":"Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2024-12-01","conditions":"Diffuse Hemispheric Glioma, H3 G34-Mutant","enrollment":""},{"nctId":"NCT04968366","phase":"PHASE1","title":"Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2021-07-30","conditions":"Glioblastoma Multiforme of Brain","enrollment":11},{"nctId":"NCT01204684","phase":"PHASE2","title":"Dendritic Cell Vaccine for Patients With Brain Tumors","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2010-10-08","conditions":"Glioma, Anaplastic Astrocytoma, Anaplastic Astro-oligodendroglioma","enrollment":24},{"nctId":"NCT02061423","phase":"PHASE1","title":"HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2014-04-08","conditions":"Breast Cancer","enrollment":7},{"nctId":"NCT03927222","phase":"PHASE2","title":"Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma","status":"TERMINATED","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2019-09-30","conditions":"Glioblastoma","enrollment":6},{"nctId":"NCT02546102","phase":"PHASE3","title":"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma","status":"SUSPENDED","sponsor":"Precision Life Sciences Group","startDate":"2024-12","conditions":"Glioblastoma Multiforme","enrollment":234},{"nctId":"NCT00019890","phase":"PHASE2","title":"Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"","conditions":"Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma","enrollment":""},{"nctId":"NCT03671720","phase":"EARLY_PHASE1","title":"Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden","status":"WITHDRAWN","sponsor":"Capital Medical University","startDate":"2018-09-11","conditions":"Advanced Cancer, Metastatic Cancer","enrollment":""},{"nctId":"NCT01957956","phase":"EARLY_PHASE1","title":"Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-11-11","conditions":"Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma","enrollment":21},{"nctId":"NCT03803397","phase":"PHASE1","title":"Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma","status":"UNKNOWN","sponsor":"PrimeVax Immuno-Oncology Inc.","startDate":"2024-04-01","conditions":"Metastatic Melanoma","enrollment":10},{"nctId":"NCT03360708","phase":"EARLY_PHASE1","title":"Vaccine Therapy in Treating Patients With Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-11-27","conditions":"Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma","enrollment":20},{"nctId":"NCT04679194","phase":"PHASE1","title":"Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT","status":"TERMINATED","sponsor":"Mana Therapeutics","startDate":"2020-12-08","conditions":"AML/MDS","enrollment":11},{"nctId":"NCT02479230","phase":"PHASE1","title":"Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients","status":"COMPLETED","sponsor":"Joseph Baar, MD, PhD","startDate":"2015-07-17","conditions":"Breast Cancer, Metastatic Breast Cancer","enrollment":18},{"nctId":"NCT00972309","phase":"PHASE1","title":"A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-05-11","conditions":"Prostate Specific Antigens, Prostate Neoplasms","enrollment":41},{"nctId":"NCT01946373","phase":"PHASE1","title":"T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma","status":"UNKNOWN","sponsor":"Karolinska University Hospital","startDate":"2013-10","conditions":"Melanoma","enrollment":20},{"nctId":"NCT04105582","phase":"PHASE1","title":"Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells","status":"COMPLETED","sponsor":"Universidad Nacional de Colombia","startDate":"2019-08-01","conditions":"Breast Cancer, Triple Negative Breast Cancer","enrollment":5},{"nctId":"NCT00045968","phase":"PHASE3","title":"Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer","status":"UNKNOWN","sponsor":"Northwest Biotherapeutics","startDate":"2006-12","conditions":"Glioblastoma Multiforme, Glioblastoma, GBM","enrollment":348},{"nctId":"NCT05317325","phase":"PHASE1","title":"A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC","status":"UNKNOWN","sponsor":"Sichuan University","startDate":"2022-04-01","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT02010606","phase":"PHASE1","title":"Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2014-01-08","conditions":"Glioblastoma, Glioblastoma Multiforme, Glioma","enrollment":39},{"nctId":"NCT04879888","phase":"PHASE1","title":"Personalized Vaccine for Cancer Immunotherapy","status":"COMPLETED","sponsor":"Universidad Nacional de Colombia","startDate":"2016-08","conditions":"Breast Cancer Female","enrollment":9},{"nctId":"NCT01635283","phase":"PHASE2","title":"Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2012-01-10","conditions":"Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma","enrollment":5},{"nctId":"NCT04567069","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment","status":"UNKNOWN","sponsor":"The Second Hospital of Shandong University","startDate":"2020-09","conditions":"Gastric Cancer","enrollment":45},{"nctId":"NCT00107185","phase":"PHASE1","title":"Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2005-01","conditions":"Brain and Central Nervous System Tumors","enrollment":7},{"nctId":"NCT00022334","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Treating Patients With Liver Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2001-01","conditions":"Liver Cancer","enrollment":33},{"nctId":"NCT00068510","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Malignant Glioma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2003-06","conditions":"Brain and Central Nervous System Tumors","enrollment":28},{"nctId":"NCT03014804","phase":"PHASE2","title":"Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma","status":"WITHDRAWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2019-12-01","conditions":"Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma","enrollment":""},{"nctId":"NCT02224599","phase":"PHASE1, PHASE2","title":"Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies","status":"TERMINATED","sponsor":"Kiromic BioPharma Inc.","startDate":"2017-07-28","conditions":"Progressive Solid Malignancies, Refractory Solid Malignancies, Cancer","enrollment":3},{"nctId":"NCT02718391","phase":"PHASE2","title":"Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.","status":"TERMINATED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2015-08","conditions":"Malignant Melanoma, Adjuvant Drug Therapy, Vaccin Therapy","enrollment":12},{"nctId":"NCT02061332","phase":"PHASE1, PHASE2","title":"DC Vaccine for Patients With Ductal Carcinoma In Situ","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2009-07","conditions":"Breast Cancer, DCIS","enrollment":58},{"nctId":"NCT02496520","phase":"PHASE1, PHASE2","title":"Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults","status":"COMPLETED","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","startDate":"2014-09-30","conditions":"Sarcoma, Central Nervous System Tumor","enrollment":6},{"nctId":"NCT04199559","phase":"PHASE1, PHASE2","title":"Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer","status":"UNKNOWN","sponsor":"Henan Cancer Hospital","startDate":"2019-12-01","conditions":"NSCLC","enrollment":30},{"nctId":"NCT03114631","phase":"PHASE1, PHASE2","title":"Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer","status":"COMPLETED","sponsor":"The Republican Research and Practical Center for Epidemiology and Microbiology","startDate":"2017-01-09","conditions":"Dendritic Cells, Pancreatic Neoplasms","enrollment":30},{"nctId":"NCT00478452","phase":"PHASE1","title":"Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2005-08","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma","enrollment":14},{"nctId":"NCT02709993","phase":"PHASE1, PHASE2","title":"Consolidation Therapy in Patients With Hematologic Malignancies","status":"WITHDRAWN","sponsor":"Kiromic BioPharma Inc.","startDate":"2017-07-28","conditions":"Cancer, Hematologic Malignancies","enrollment":""},{"nctId":"NCT00937183","phase":"NA","title":"Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma","status":"COMPLETED","sponsor":"Jan Walewski","startDate":"2003-09","conditions":"Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":12},{"nctId":"NCT00576537","phase":"PHASE2","title":"Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2001-03","conditions":"Glioblastoma","enrollment":50},{"nctId":"NCT02070406","phase":"PHASE1","title":"Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies","status":"TERMINATED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2014-07-17","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":4},{"nctId":"NCT03226236","phase":"PHASE2","title":"Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC","status":"WITHDRAWN","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2016-03","conditions":"Carcinoma, Renal Cell, Vaccination, Secondary","enrollment":""},{"nctId":"NCT00868114","phase":"PHASE2","title":"Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer","status":"TERMINATED","sponsor":"Leo W. Jenkins Cancer Center","startDate":"2006-07","conditions":"Metastatic Pancreatic Cancer","enrollment":24},{"nctId":"NCT00266110","phase":"PHASE2","title":"Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2005-12","conditions":"Breast Cancer","enrollment":17},{"nctId":"NCT02223312","phase":"PHASE1, PHASE2","title":"Therapy for Progressive and/or Refractory Hematologic Malignancies","status":"WITHDRAWN","sponsor":"Kiromic BioPharma Inc.","startDate":"2017-07-28","conditions":"Cancer, Hematologic Malignancies","enrollment":""},{"nctId":"NCT02705703","phase":"PHASE1, PHASE2","title":"Consolidation Therapy in Patients With Metastatic Solid Malignancies","status":"WITHDRAWN","sponsor":"Kiromic BioPharma Inc.","startDate":"2017-07-28","conditions":"Cancer, Metastatic Solid Malignancies","enrollment":""},{"nctId":"NCT00923351","phase":"PHASE1, PHASE2","title":"Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-06-02","conditions":"Neuroblastoma, Sarcoma, Rhabdomyosarcoma-Embryonal","enrollment":44},{"nctId":"NCT02332889","phase":"PHASE1, PHASE2","title":"Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs","status":"TERMINATED","sponsor":"University of Louisville","startDate":"2015-04","conditions":"Gliomas, Medulloblastoma, Neuroectodermal Tumors, Primitive","enrollment":1},{"nctId":"NCT01159288","phase":"PHASE2","title":"Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2010-05-19","conditions":"Non Small Cell Lung Cancer","enrollment":41},{"nctId":"NCT02840123","phase":"PHASE1","title":"Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines","status":"UNKNOWN","sponsor":"Fundació Sant Joan de Déu","startDate":"2016-06","conditions":"Diffuse Intrinsic Pontine Glioma","enrollment":10},{"nctId":"NCT01617629","phase":"PHASE2","title":"Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study","status":"COMPLETED","sponsor":"Prima BioMed Ltd","startDate":"2011-12","conditions":"Epithelial Ovarian Cancer","enrollment":9},{"nctId":"NCT00944580","phase":"PHASE1","title":"A Vaccine Study for High Risk Cancers","status":"WITHDRAWN","sponsor":"Penn State University","startDate":"2009-06","conditions":"Neuroblastoma, Rhabdomyosarcoma, Osteogenic Sarcoma","enrollment":""},{"nctId":"NCT00405327","phase":"PHASE2","title":"A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2006-06","conditions":"Sarcoma, Neuroblastoma, Wilm's Tumor","enrollment":16},{"nctId":"NCT01671592","phase":"PHASE1","title":"Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)","status":"COMPLETED","sponsor":"Pawel Kalinski","startDate":"2013-01","conditions":"Colorectal Neoplasms, Colorectal Cancer, Colorectal Carcinoma","enrollment":6},{"nctId":"NCT02602249","phase":"PHASE1","title":"Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.","status":"UNKNOWN","sponsor":"Beijing Doing Biomedical Co., Ltd.","startDate":"2017-10","conditions":"Gastric Cancer","enrollment":24},{"nctId":"NCT02745756","phase":"PHASE1","title":"A Combined Cell Therapy Approach to the Treatment of Neuroblastoma","status":"WITHDRAWN","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2016-04-14","conditions":"Neuroblastoma, Neoplasms, Nerve Tissue","enrollment":""},{"nctId":"NCT01398124","phase":"NA","title":"Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2012-12","conditions":"Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT01042366","phase":"PHASE2","title":"Dendritic Cells (DC) Vaccine for Metastatic Melanoma","status":"TERMINATED","sponsor":"John Kirkwood","startDate":"2002-10","conditions":"Metastatic Melanoma","enrollment":16},{"nctId":"NCT01483274","phase":"PHASE1","title":"Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2015-03","conditions":"Acute Myelogenous Leukemia","enrollment":""},{"nctId":"NCT01241162","phase":"PHASE1","title":"Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2010-08","conditions":"Neuroblastoma, Ewings Sarcoma, Osteogenic Sarcoma","enrollment":19},{"nctId":"NCT01792505","phase":"PHASE1","title":"Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2009-10","conditions":"Malignant Glioma","enrollment":71},{"nctId":"NCT00923910","phase":"PHASE1, PHASE2","title":"Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-02-22","conditions":"Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL), Leukemia, Chronic Myelogenous (CML)","enrollment":10},{"nctId":"NCT01280552","phase":"PHASE2","title":"A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)","status":"COMPLETED","sponsor":"Precision Life Sciences Group","startDate":"2011-01","conditions":"Glioblastoma Multiforme","enrollment":124},{"nctId":"NCT01521143","phase":"PHASE2","title":"Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment","status":"TERMINATED","sponsor":"Prima BioMed Ltd","startDate":"2012-01","conditions":"Epithelial Ovarian Cancer","enrollment":91},{"nctId":"NCT02215837","phase":"PHASE2","title":"Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer","status":"UNKNOWN","sponsor":"Shenzhen Hornetcorn Bio-technology Company, LTD","startDate":"2014-08","conditions":"Gastric Cancer, Neoplasms, Gastrointestinal Neoplasms","enrollment":40},{"nctId":"NCT01431196","phase":"PHASE2","title":"Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer","status":"COMPLETED","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","startDate":"2011-02","conditions":"Stage II Breast Cancer, Stage III Breast Cancer","enrollment":29},{"nctId":"NCT00345293","phase":"PHASE1, PHASE2","title":"Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer","status":"COMPLETED","sponsor":"Rockefeller University","startDate":"2006-06","conditions":"Prostate Cancer","enrollment":13},{"nctId":"NCT00404339","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Head and Neck Cancer","status":"COMPLETED","sponsor":"Robert Ferris","startDate":"2005-09","conditions":"Head and Neck Cancer","enrollment":17},{"nctId":"NCT02146066","phase":"","title":"Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221","status":"AVAILABLE","sponsor":"Northwest Biotherapeutics","startDate":"","conditions":"GBM, Glioblastoma Multiforme","enrollment":""},{"nctId":"NCT00612001","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Malignant Glioma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2006-05","conditions":"Brain and Central Nervous System Tumors","enrollment":8},{"nctId":"NCT01783431","phase":"PHASE1","title":"Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells","status":"TERMINATED","sponsor":"Medical University of South Carolina","startDate":"2012-10","conditions":"Melanoma","enrollment":1},{"nctId":"NCT01897207","phase":"PHASE1, PHASE2","title":"Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer","status":"COMPLETED","sponsor":"Cantonal Hospital of St. Gallen","startDate":"2002-11","conditions":"Cancer of the Prostate","enrollment":15},{"nctId":"NCT02503150","phase":"PHASE3","title":"Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer","status":"UNKNOWN","sponsor":"Second Military Medical University","startDate":"2015-07","conditions":"Metastatic Colorectal Cancer","enrollment":480},{"nctId":"NCT02310971","phase":"PHASE2","title":"Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas","status":"WITHDRAWN","sponsor":"Prima BioMed Ltd","startDate":"2015-02","conditions":"Pancreatic Carcinoma Stage I, Pancreatic Carcinoma Stage II","enrollment":""},{"nctId":"NCT02395679","phase":"PHASE1","title":"Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2015-01","conditions":"Mesothelioma","enrollment":9},{"nctId":"NCT00124124","phase":"PHASE1","title":"Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine","status":"COMPLETED","sponsor":"Dr. Nina Bhardwaj","startDate":"2005-07","conditions":"Melanoma","enrollment":50},{"nctId":"NCT00893945","phase":"PHASE1","title":"Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors","status":"COMPLETED","sponsor":"Rockefeller University","startDate":"2007-06","conditions":"Brain Tumors","enrollment":19},{"nctId":"NCT00576641","phase":"PHASE1","title":"Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2007-05","conditions":"Brain Stem Glioma, Glioblastoma","enrollment":22},{"nctId":"NCT00107211","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2005-01","conditions":"Breast Cancer","enrollment":30},{"nctId":"NCT00057915","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer","status":"COMPLETED","sponsor":"Duke University","startDate":"2003-09","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":4},{"nctId":"NCT01006044","phase":"PHASE2","title":"Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection","status":"COMPLETED","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","startDate":"2009-10","conditions":"Glioblastoma Multiforme","enrollment":26},{"nctId":"NCT00005956","phase":"NA","title":"Biological Therapy in Treating Patients With Advanced Cancer","status":"COMPLETED","sponsor":"Duke University","startDate":"2000-02","conditions":"Breast Cancer, Gastric Cancer, Ovarian Cancer","enrollment":3},{"nctId":"NCT00006113","phase":"PHASE2","title":"Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma","status":"TERMINATED","sponsor":"University of Southern California","startDate":"1999-06","conditions":"Melanoma (Skin)","enrollment":25},{"nctId":"NCT00334776","phase":"PHASE2","title":"Vaccine Therapy in Treating Patients With Metastatic Melanoma","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2003-10","conditions":"Intraocular Melanoma, Melanoma (Skin)","enrollment":6},{"nctId":"NCT01241682","phase":"PHASE1","title":"Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2009-10","conditions":"Malignant (Pleural) Mesothelioma","enrollment":10},{"nctId":"NCT00313508","phase":"PHASE1","title":"Dendritic Cell Vaccination During Lymphoid Reconstruction","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2006-02","conditions":"Intraocular Melanoma, Melanoma (Skin)","enrollment":18},{"nctId":"NCT00003434","phase":"PHASE1","title":"Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer","status":"TERMINATED","sponsor":"Duke University","startDate":"1998-06","conditions":"Pancreatic Cancer","enrollment":8},{"nctId":"NCT00107159","phase":"PHASE2","title":"Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2005-01","conditions":"Melanoma (Skin)","enrollment":37},{"nctId":"NCT00003432","phase":"PHASE1, PHASE2","title":"Immunotherapy in Treating Patients With Metastatic Breast Cancer","status":"TERMINATED","sponsor":"Duke University","startDate":"1998-06","conditions":"Breast Cancer","enrollment":4},{"nctId":"NCT00003433","phase":"PHASE1, PHASE2","title":"Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer","status":"COMPLETED","sponsor":"Duke Cancer Institute","startDate":"1998-06","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":""},{"nctId":"NCT00019084","phase":"PHASE2","title":"Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1996-02","conditions":"Breast Cancer, Cervical Cancer, Colorectal Cancer","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"tumor-pulsed dendritic cells","genericName":"tumor-pulsed dendritic cells","companyName":"National Center for Research Resources (NCRR)","companyId":"national-center-for-research-resources-ncrr","modality":"Biologic","firstApprovalDate":"","aiSummary":"Tumor-pulsed dendritic cells are being studied in clinical trials for various types of cancer, including AML/MDS, advanced cancer, metastatic cancer, melanoma, and non-small cell lung cancer. The specific interventions used in these trials include personalized DC vaccines and autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccines, but the exact mechanism of action is currently unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}